Baidu
map
CARDIOLOGY 润色咨询

CARDIOLOGY

出版年份:1970 年文章数:1418 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:3.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=0f0e1335, cover=https://img.medsci.cn/images/journal/cover/2021/BJD_202109271314380250.jpg, fullname=CARDIOLOGY, abbr=CARDIOLOGY, pyear=1970, frequence=Bimonthly, articleNumbers=1418, citedSelf2015=3.2, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1.78月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0008-6312, greenSci=https://www.greensci.net/search?kw=0008-6312, scijournal=https://www.scijournal.org/impact-factor-of-CARDIOLOGY.shtml, medsciHotlightString=null, medsciHotlightRealtime=6.813, medsciHotlight=12.565, medsciHotlight5year=15.0445, citescore=3.4, hIndex=63, impactFactor=1.9, orgnization=S. Karger AG, orgnizationUrl=http://www.karger.ch, country=Switzerland, countryCn=瑞典, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 4区, smallclassCas=医学 4 区, website=http://www.karger.com/Journal/Home/223832, websiteHits=27409, guideForAuthor=, guideForAuthorHits=32, submitWebsite=https://oper1.karger.com/journals/default.asp?ProduktNr=223832, submitWebsiteHits=8594, content=Cardiologyí features high-quality papers from all over the world to keep its readers regularly informed of current strategies in the prevention, diagnosis and treatment of heart disease. These papers not only describe but offer critical appraisals of new developments in non-invasive, invasive, diagnostic and therapeutic methods. The importance of experimental work is also acknowledged through reports covering the function and metabolism of the heart and the morphology and physiology of cardiovascular disease. Special sections in a variety of subspecialty areas reinforce the journalís value as a complete record of recent progress for all cardiologists, internists, cardiac surgeons and clinical physiologists.<div><br></div><div>''Cardiology'' publishes original reports in research and observations pertaining to cardiovascular physiology, epidemiology, pharmacology, disease and therapy.<br><br>Only original papers written in English are considered. The articles should be readily comprehensible to a reader who is fluent in English. Therefore, all manuscripts originating from non-English-speaking authors must be edited prior to submission to assure that standard English grammar and usage are observed. This may require help from a colleague or other editorial assistant. It must be evident from the covering letter that this has been done. Submissions that are not edited in this way will not be considered for publication until such editing has been achieved.<br><br><span style="font-weight: bold;">Manuscripts should be submitted online</span></div><div><a href="http://oper1.karger.com/journals/default.asp?ProduktNr=223832" style="outline: none;">Online Manuscript Submission</a> </div><div><span style="font-weight: bold;"><br></span></div><div><span class="titel2" style="font-weight: bold;">Main Sections</span><br><br><ol style="padding: 0px; margin: 0px 0px 20px 25px;"><li style="margin-left: 30px;">Original Research</li><li style="margin-left: 30px;">Original Research – Clinical Trial Design<br>Submissions will be accepted reporting the study design protocols of planned clinical trials that have been appropriately registered with regulatory authorities. These submissions will be limited to 4500 words and 35 references.</li><li style="margin-left: 30px;">Review</li><li style="margin-left: 30px;">Turning Basic Research into Clinical Success<br>One or two focused review articles are published in each issue, and should offer an overview of existing concepts and literature in a format assimilable to the largely clinical cardiologist readership, i.e. a readership base with limited sophistication as to methods and terminology associated with cell and molecular biology. Most manuscripts are submitted upon invitation. Authors planning to submit an unsolicited paper are requested to contact the Editorial Office with an outline of the intended contribution. All submissions are subject to peer review. These articles are available also to nonsubscribers in free access on the journal''s website. Submissions should comprise no more than 4,500 words and 50 references. They should have an abstract of approximately 200 words and about 5 key words should be provided.</li><li style="margin-left: 30px;">Letter to the Editor<br>Letters to the Editor (max. 1,500 words, including references) are encouraged if they directly concern articles previously published in this journal and issues raised by those articles. The Editor reserves the right to submit copies of such letters to the authors of the articles concerned prior to publication in order to permit them to respond in the same issue of the journal.</li><li style="margin-left: 30px;">Novel Insights from Clinical Experience (formerly Case Reports)<br>Contributions to this section are expected to provide novel insight into a clinical problem. Submissions can be based on a single case or a number of similar cases. While a case report can describe an entirely novel clinical condition, we recognise that it is unlikely that most case reports will provide such information. In the more common setting of a description of a well-recognized condition, the most important aspect of the presentation, on which editorial judgments will be based, is the description of the new perspective(s) on the phenotype, pathophysiology, clinical presentation, evaluation strategy and/or management that can be drawn from the case findings.<br><br>Highlighted boxes containing one or two bullet points on ''Established facts''and ''Novel insights'' are required and should be placed on the first page of the report. These should be selected so as to reinforce the novelty of the clinical observation.<br><br>Example<br><table cellspacing="1" cellpadding="6" border="1" frame="box" bgcolor="EBCCD3" style="max-width: 100%; border-collapse: collapse; border-spacing: 0px; margin: 10px 0px; border-color: rgb(204, 204, 204);"><tbody><tr><td style="padding: 4px;">Established Facts<br><br>  ·    Already known fact 1 ...      <br><br>  ·    Already known fact 2 ... <br><br>  ·     ...</td></tr></tbody></table><br><table cellspacing="1" cellpadding="6" border="1" frame="box" bgcolor="EBCCD3" style="max-width: 100%; border-collapse: collapse; border-spacing: 0px; margin: 10px 0px; border-color: rgb(204, 204, 204);"><tbody><tr><td style="padding: 4px;">Novel Insights <br><br>  ·    New information 1 ...          <br><br>  ·    New information 2 ... <br><br>  ·     ...</td></tr></tbody></table><br>The manuscript should be presented with an abstract (up to 200 words), brief introduction, case or case series description and results, followed by a discussion. "Novel Insights from Clinical Experience" should be no more than 2,500 words (including statements in the highlighted box) and should contain no more than 20 references. Please note that case reports that are not submitted in this format will not be considered, and that such reports cannot be submitted as Letters to the Editor.</li><li style="margin-left: 30px;">Short Communications<br>These manuscripts should not contain more than 2,000 words, including key words, essential references (not more than 15) and not more than 3 tables or figures. Such communications should represent complete, original studies and should be arranged in the same way as full length manuscripts.</li><li style="margin-left: 30px;">Commentary<br>Authors who wish to contribute a manuscript to this category should contact the Editor. Commentaries should offer a more personalized perspective on a topic that will be of interest to the general readership, paralleling Editorials (defined as commentaries invited by the Editors or opinion pieces produced by members of our editorial board). All contributions to this category will be subject to editorial review for relevance for the readership, perception of topicality and general importance/interest, and quality of the submitted work. To submit a "Letter to the Editor", see point 5. above.</li></ol></div>, totalCites=2696, brief=CARDIOLOGY杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=心血管系统" >心血管系统</a></strong>”子行业的偏低级别杂志, articleType=论著为主,其它类型文章约占5-10%, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='//m.capotfarm.com/sci/submit.do?id=0f0e1335'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=1517, tagName=临床研究, createdHits=6), ImpactFactorTagDto(id=2529, tagName=心血管疾病, createdHits=3), ImpactFactorTagDto(id=266, tagName=心血管, createdHits=3), ImpactFactorTagDto(id=6352, tagName=基础研究, createdHits=1), ImpactFactorTagDto(id=60662, tagName=扩心病, createdHits=1), ImpactFactorTagDto(id=471, tagName=遗传, createdHits=1), ImpactFactorTagDto(id=1475, tagName=基因组学, createdHits=1), ImpactFactorTagDto(id=517, tagName=血小板, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2017, citescore=1.16), GetImpactFactorCiteScoreListResponse(year=2018, citescore=1.25), GetImpactFactorCiteScoreListResponse(year=2019, citescore=2.9), GetImpactFactorCiteScoreListResponse(year=2020, citescore=2.7), GetImpactFactorCiteScoreListResponse(year=2023, citescore=3.4)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=15.135), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=13.07), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=11.276), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=9.401), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=6.813)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Cardiology and Cardiovascular Medicine , rank=171/322), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Pharmacology (medical) , rank=136/232)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=CARDIAC & CARDIOVASCULAR SYSTEMS, rank=Q3)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0008-6312[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CARDIOLOGY[ta], article_number=74, article_number_cn=12, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
CARDIOLOGY/CARDIOLOGY
ISSN
0008-6312
影响指数话题
预警等级
MedSci期刊指数
6.813 (MedSci实时期刊指数) | 15.0445 (5年期刊指数)
CiteScore值
3.4
h-index
63
h5-median
暂无数据
出版社/管理机构
杂志由 S. Karger AG 出版或管理
出版国家/地区
Switzerland 瑞典
出版周期
Bimonthly
出版年份
1970
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|Current Contents - Life Sciences|BIOSIS Previews
JCR分区
CARDIAC & CARDIOVASCULAR SYSTEMS Q3
中科院分区
大类:医学 4区
小类:医学 4 区
Baidu
map
Baidu
map
Baidu
map